RecoveryResearch Phase

BPC-157

Subcutaneous injection, Oral

Overview

A synthetic gastric pentadecapeptide derived from a protein found in human gastric juice. BPC-157 promotes angiogenesis and the expression of growth factors including VEGF, EGF, and NO-mediated pathways.

Mechanism of Action

It has demonstrated cytoprotective and wound-healing properties across multiple tissue types in preclinical models, including tendon, muscle, ligament, and gastrointestinal mucosa..

Research Summary & Key Findings

Accelerated tendon-to-bone healing and reduced inflammation in rat models (J Orthop Res, 2010). Protective effects on gastric mucosa and intestinal anastomosis healing demonstrated in multiple animal studies.

Clinical Status

Research Phase

BPC-157 is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.

Administration Routes

Subcutaneous injectionOral

Related Peptides in Recovery

Find a Provider

Find a verified provider who offers BPC-157 therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply BPC-157.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.